Pemetrexed plus platinum as the first-line treatment option for advanced non-small cell lung cancer: a meta-analysis of randomized controlled trials.

Pemetrexed plus platinum as the first-line treatment option for advanced non-small cell lung cancer: a meta-analysis of randomized controlled trials.

To compare the efficacy and toxicities of pemetrexed plus platinum with other platinum regimens in patients with previously untreated advanced non-small cell lung cancer (NSCLC).A meta-analysis was performed using trials identified through PubMed, EMBASE, and Cochrane databases. Two investigators in...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Ming Li, Qian Zhang, Peifang Fu, Ping Li, Aimei Peng, Guoliang Zhang, Xiaolian Song, Min Tan, Xuan Li, Yang Liu, Yueping Wu, Suyun Fan, Changhui Wang
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Public Library of Science (PLoS) 2012-01-01
Saila:PLoS ONE
Sarrera elektronikoa:http://europepmc.org/articles/PMC3355109?pdf=render

Internet

http://europepmc.org/articles/PMC3355109?pdf=render

Antzeko izenburuak